Search

Ruth A. Davis

Examiner (ID: 13622, Phone: (571)272-0915 , Office: P/1651 )

Most Active Art Unit
1651
Art Unit(s)
1651, 1699
Total Applications
1634
Issued Applications
801
Pending Applications
225
Abandoned Applications
618

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19249065 [patent_doc_number] => 20240200052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => METHOD FOR PRODUCING TAGATOSE FROM BIOMIMETIC SILICON MINERALIZED MICROCAPSULE IMMOBILIZED MULTI-ENZYME [patent_app_type] => utility [patent_app_number] => 18/554464 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4716 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554464 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/554464
METHOD FOR PRODUCING TAGATOSE FROM BIOMIMETIC SILICON MINERALIZED MICROCAPSULE IMMOBILIZED MULTI-ENZYME Feb 10, 2022 Pending
Array ( [id] => 19114039 [patent_doc_number] => 20240125789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => HYBRID AMEBOCYTE LYSATE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/275777 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17473 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275777 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/275777
HYBRID AMEBOCYTE LYSATE AND USES THEREOF Feb 10, 2022 Abandoned
Array ( [id] => 17928320 [patent_doc_number] => 20220323445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => REDUCING IMMUNOGENICITY TO PEGLOTICASE [patent_app_type] => utility [patent_app_number] => 17/668015 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668015 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/668015
REDUCING IMMUNOGENICITY TO PEGLOTICASE Feb 8, 2022 Abandoned
Array ( [id] => 17733335 [patent_doc_number] => 20220218794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => COMPOSITIONS AND METHODS FOR DETOXIFYING BACTERIAL ENDOTOXINS [patent_app_type] => utility [patent_app_number] => 17/592623 [patent_app_country] => US [patent_app_date] => 2022-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8301 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592623 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/592623
COMPOSITIONS AND METHODS FOR DETOXIFYING BACTERIAL ENDOTOXINS Feb 3, 2022 Abandoned
Array ( [id] => 19947074 [patent_doc_number] => 12318412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-03 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 17/577208 [patent_app_country] => US [patent_app_date] => 2022-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 6663 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17577208 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/577208
None Jan 16, 2022 Issued
Array ( [id] => 18988128 [patent_doc_number] => 20240060097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => BIOCONVERSION OF FERULIC ACID TO VANILLIN [patent_app_type] => utility [patent_app_number] => 18/267478 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12804 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267478 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/267478
BIOCONVERSION OF FERULIC ACID TO VANILLIN Dec 16, 2021 Abandoned
Array ( [id] => 17519313 [patent_doc_number] => 20220105161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME [patent_app_type] => utility [patent_app_number] => 17/551942 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551942 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/551942
PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME Dec 14, 2021 Abandoned
Array ( [id] => 18986459 [patent_doc_number] => 20240058428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => COMPOSITION FOR TREATING OR PREVENTING MYOPATHY, OBESITY OR DIABETES [patent_app_type] => utility [patent_app_number] => 18/267252 [patent_app_country] => US [patent_app_date] => 2021-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7803 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267252 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/267252
Composition for treating or preventing myopathy, obesity or diabetes Dec 13, 2021 Issued
Array ( [id] => 18988140 [patent_doc_number] => 20240060109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => Process for the production of a filamentous fungus whole broth enzyme composition with low viscosity [patent_app_type] => utility [patent_app_number] => 18/267276 [patent_app_country] => US [patent_app_date] => 2021-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12641 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267276 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/267276
Process for the production of a filamentous fungus whole broth enzyme composition with low viscosity Dec 12, 2021 Abandoned
Array ( [id] => 18986786 [patent_doc_number] => 20240058755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => CONTINUOUS ENZYMATIC PERFUSION REACTOR SYSTEM [patent_app_type] => utility [patent_app_number] => 18/265838 [patent_app_country] => US [patent_app_date] => 2021-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265838 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265838
CONTINUOUS ENZYMATIC PERFUSION REACTOR SYSTEM Dec 12, 2021 Abandoned
Array ( [id] => 20218650 [patent_doc_number] => 20250281581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => METHODS OF CANCER TREATMENT BY INTRATUMORAL INJECTION OF MUTANT COLLAGENASE [patent_app_type] => utility [patent_app_number] => 18/259576 [patent_app_country] => US [patent_app_date] => 2021-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 958 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259576 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/259576
METHODS OF CANCER TREATMENT BY INTRATUMORAL INJECTION OF MUTANT COLLAGENASE Dec 8, 2021 Pending
Array ( [id] => 19065536 [patent_doc_number] => 20240099962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/256325 [patent_app_country] => US [patent_app_date] => 2021-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88990 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256325 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/256325
COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS Dec 7, 2021 Pending
Array ( [id] => 18923403 [patent_doc_number] => 20240026407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => MODIFICATION OF SAPONINS [patent_app_type] => utility [patent_app_number] => 18/039514 [patent_app_country] => US [patent_app_date] => 2021-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71484 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039514 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/039514
MODIFICATION OF SAPONINS Dec 7, 2021 Pending
Array ( [id] => 17654494 [patent_doc_number] => 20220174959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => STREPTOMYCES ANTIOXIDANS AND ITS USE IN PREVENTION AND TREATMENT OF PLANT DISEASES [patent_app_type] => utility [patent_app_number] => 17/544717 [patent_app_country] => US [patent_app_date] => 2021-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544717 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/544717
None Dec 6, 2021 Issued
Array ( [id] => 20220213 [patent_doc_number] => 20250283144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => ELEVATION OF GLYCOSAMINOGLYCANS IN SUBJECTS WITHOUT MUCOPOLYSACCHARIDOSIS [patent_app_type] => utility [patent_app_number] => 18/265076 [patent_app_country] => US [patent_app_date] => 2021-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265076 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265076
ELEVATION OF GLYCOSAMINOGLYCANS IN SUBJECTS WITHOUT MUCOPOLYSACCHARIDOSIS Dec 6, 2021 Pending
Array ( [id] => 18877490 [patent_doc_number] => 20240000859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => DESIGNED BACTERIAL COMPOSITIONS FOR TREATING GRAFT-VERSUS-HOST-DISEASE [patent_app_type] => utility [patent_app_number] => 18/254449 [patent_app_country] => US [patent_app_date] => 2021-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58081 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -129 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254449 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/254449
DESIGNED BACTERIAL COMPOSITIONS FOR TREATING GRAFT-VERSUS-HOST-DISEASE Nov 23, 2021 Pending
Array ( [id] => 18879410 [patent_doc_number] => 20240002779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => Functionalization of Mycelium Materials [patent_app_type] => utility [patent_app_number] => 18/254129 [patent_app_country] => US [patent_app_date] => 2021-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -67 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254129 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/254129
Functionalization of Mycelium Materials Nov 23, 2021 Abandoned
Array ( [id] => 19018941 [patent_doc_number] => 20240075112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => SCAR TREATMENT COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/038576 [patent_app_country] => US [patent_app_date] => 2021-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16982 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038576 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/038576
SCAR TREATMENT COMPOSITION Nov 23, 2021 Pending
Array ( [id] => 19431008 [patent_doc_number] => 20240299506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => WOUND HEALING [patent_app_type] => utility [patent_app_number] => 18/252995 [patent_app_country] => US [patent_app_date] => 2021-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8350 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252995 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/252995
WOUND HEALING Nov 22, 2021 Pending
Array ( [id] => 18877532 [patent_doc_number] => 20240000901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => USE OF POLYPEPTIDE HAVING SUPEROXIDE DISMUTASE ACTIVITY AND EXTRACELLULAR VESICLES FOR TREATMENT OR PREVENTION OF RESPIRATORY VIRAL INFECTION [patent_app_type] => utility [patent_app_number] => 18/038143 [patent_app_country] => US [patent_app_date] => 2021-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038143 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/038143
USE OF POLYPEPTIDE HAVING SUPEROXIDE DISMUTASE ACTIVITY AND EXTRACELLULAR VESICLES FOR TREATMENT OR PREVENTION OF RESPIRATORY VIRAL INFECTION Nov 22, 2021 Abandoned
Menu